MNPR earnings: a positive outcome, +7.3%

On November 8, 2024, Monopar Therapeutics reached its earnings. The result was a positive outcome, and the stock moved +7.3% in the window around the event. It had already run +210.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.